May 30 is World MS Day. I’d like to take the opportunity to discuss the importance of pharmacogenomics in providing complete care for patients with multiple sclerosis.
Conservatives say the federal government is offering ‘false hope’ to Canadians with a national pharmacare bill that will not initially apply to a broad range of medications.
